| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |